Covestor’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1K Buy
17
+12
+240% +$432 ﹤0.01% 2402
2026
Q1
$0 Buy
5
+3
+150% +$71 ﹤0.01% 2851
2025
Q4
$0 Sell
2
-3,231
-100% -$85.8K ﹤0.01% 2819
2025
Q3
$92K Buy
3,233
+2,192
+211% +$59.4K 0.05% 627
2025
Q2
$26K Sell
1,041
-960
-48% -$27K 0.02% 1160
2025
Q1
$62K Buy
2,001
+1,773
+778% +$59.1K 0.04% 757
2024
Q4
$7K Buy
228
+220
+2,750% +$10.4K ﹤0.01% 1684
2024
Q3
$1K Sell
8
-538
-99% -$26.4K ﹤0.01% 2133
2024
Q2
$22K Sell
546
-40
-7% -$1.59K 0.01% 1173
2024
Q1
$25K Buy
586
+581
+11,620% +$22.7K 0.02% 1145
2023
Q4
$0 Sell
5
-3
-38% -$100 ﹤0.01% 2799
2023
Q3
$0 Buy
8
+3
+60% +$104 ﹤0.01% 2797
2023
Q2
$0 Hold
5
﹤0.01% 2738
2023
Q1
$0 Hold
5
﹤0.01% 2667
2022
Q4
$0 Buy
5
+2
+67% +$64 ﹤0.01% 2686
2022
Q3
$0 Buy
+3
New +$137 ﹤0.01% 2701

Other funds holding ASTH

Covestor's ASTH Position: Q2 2026 in Review

Covestor increased its Astrana Health (ASTH) stake by 240% in Q2 2026, buying an estimated $432 and bringing the position to 17 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2402.

Covestor first reported a position in ASTH in Q3 2022 and has held it in 16 quarters since. The position peaked at $92K in Q3 2025. 74 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Covestor held 17 shares of Astrana Health worth $1K as of Q2 2026.
  • Covestor bought 12 Astrana Health shares in Q2 2026, an estimated $432.
  • Astrana Health made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2402 holding.
  • Covestor first reported a position in Astrana Health in Q3 2022 and has held it in 16 quarters since.
  • Covestor's Astrana Health position peaked at $92K in Q3 2025.
  • 74 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.